about
Chemotherapy for metastatic and recurrent cervical cancerProspective Validation of Pooled Prognostic Factors in Women with Advanced Cervical Cancer Treated with Chemotherapy with/without Bevacizumab: NRG Oncology/GOG Study.The ganglioside GM3 is associated with cisplatin-induced apoptosis in human colon cancer cellsCisplatin tumor biodistribution and efficacy after intratumoral injection of a biodegradable extended release implant.URI expression in cervical cancer cells is associated with higher invasion capacity and resistance to cisplatin.RIPK3 expression in cervical cancer cells is required for PolyIC-induced necroptosis, IL-1α release, and efficient paracrine dendritic cell activationKnock down of p53 or its ubiquitin ligase E6AP does not affect the sensitivity of human papillomavirus-positive cervical cancer cells to cisplatin.Conditionally replicating E1B-deleted adenovirus driven by the squamous cell carcinoma antigen 2 promoter for uterine cervical cancer therapy.
P2860
Q24198084-297AF688-93BD-4D21-80E9-1ECA1970156BQ30354788-12FF8F1B-3885-4326-81E8-B20EC65A06CFQ33609838-14F46E88-20E4-4B52-8A6E-96E80EE39971Q35692165-2F25890E-577E-43C3-AC9C-BB373E793725Q35757985-3EEB451E-14C6-4AF4-969B-4E59AD7E0C40Q35832188-76DD5654-3F32-4E9B-BAA2-DE6C9DC1B004Q36003210-E398AE87-1471-4736-A8CC-971C357CF1F4Q39979621-7E161063-6469-4B99-B6C1-A5C94E06E8DA
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Chemotherapy for recurrent cervical carcinoma.
@ast
Chemotherapy for recurrent cervical carcinoma.
@en
type
label
Chemotherapy for recurrent cervical carcinoma.
@ast
Chemotherapy for recurrent cervical carcinoma.
@en
prefLabel
Chemotherapy for recurrent cervical carcinoma.
@ast
Chemotherapy for recurrent cervical carcinoma.
@en
P1476
Chemotherapy for recurrent cervical carcinoma.
@en
P2093
David H Moore
P304
P356
10.1097/01.CCO.0000239893.21161.51
P577
2006-09-01T00:00:00Z